nickel has been researched along with tacrolimus in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Cuyper, C; Decroix, J; Graeber, M; Lachapelle, JM; Ortonne, JP; Queille-Roussel, C; Thurston, M | 1 |
| Belsito, DV; Gadzia, JE; Saripalli, YV | 1 |
| Grimes, ML; Hendry, IA; Ozsarac, N; Weible, MW | 1 |
| Alomar, A; Gallardo, CM; Puig, L; Valenzuela, N | 1 |
| Anderson, B; Belsito, D; Ehrlich, A; Fowler, J; Rutledge, ES; Strober, BE; Warshaw, E; Willetts, J; Wilson, DC | 1 |
| Bhardwaj, SS; Jaimes, JP; Liu, A; Warshaw, EM | 1 |
| Barr, LA; Berretta, RM; Gao, H; Houser, SR; Kubo, H; Makarewich, CA; Molkentin, JD; Wang, F; Wang, W; Zhang, H | 1 |
4 trial(s) available for nickel and tacrolimus
| Article | Year |
|---|---|
Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis.
Topics: Administration, Topical; Adult; Cross-Over Studies; Dermatitis, Allergic Contact; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Nickel; Ointments; Patch Tests; Reference Values; Risk Assessment; Severity of Illness Index; Tacrolimus; Treatment Outcome | 2003 |
Topical tacrolimus 0.1% ointment (protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema.
Topics: Administration, Topical; Adult; Anti-Allergic Agents; Dermatitis, Allergic Contact; Dose-Response Relationship, Drug; Double-Blind Method; Emollients; Erythema; Female; Humans; Immunosuppressive Agents; Irritants; Middle Aged; Mometasone Furoate; Nickel; Ointments; Patch Tests; Petrolatum; Pregnadienediols; Spectrophotometry; Tacrolimus; Time Factors | 2003 |
A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Dermatitis, Allergic Contact; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Nickel; Ointments; Prospective Studies; Tacrolimus | 2006 |
A double-blind randomized placebo-controlled pilot study comparing topical immunomodulating agents and corticosteroids for treatment of experimentally induced nickel contact dermatitis.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adult; Allergens; Clobetasol; Dermatitis, Allergic Contact; Double-Blind Method; Female; Humans; Immunologic Factors; Male; Nickel; Petrolatum; Pilot Projects; Severity of Illness Index; Tacrolimus; Treatment Outcome; Triamcinolone | 2007 |
3 other study(ies) available for nickel and tacrolimus
| Article | Year |
|---|---|
SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge.
Topics: Administration, Topical; Allergens; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Allergic Contact; Dermatologic Agents; Humans; Nickel; Ointments; Patch Tests; Skin; Tacrolimus | 2000 |
Comparison of nerve terminal events in vivo effecting retrograde transport of vesicles containing neurotrophins or synaptic vesicle components.
Topics: Animals; Antibodies; Axonal Transport; Blotting, Western; Catecholamines; Dopamine beta-Hydroxylase; Dynamins; Endocytosis; Enzyme Inhibitors; Exocytosis; Immunohistochemistry; Immunosuppressive Agents; Iodine Isotopes; Ligation; Nerve Growth Factor; Nerve Growth Factors; Neurons; Nickel; Peripheral Nervous System; Presynaptic Terminals; Rats; Rats, Wistar; Sciatic Nerve; Superior Cervical Ganglion; Synaptic Vesicles; Tacrolimus; Tyrphostins | 2004 |
Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Calcium Signaling; Cardiomegaly; Cell Nucleus; Cells, Cultured; Heart Ventricles; Imidazoles; Myocytes, Cardiac; NFATC Transcription Factors; Nickel; Nifedipine; Protein Transport; Rats; Rats, Sprague-Dawley; Tacrolimus; TRPC Cation Channels; Ventricular Remodeling | 2012 |